相关实验视频
Updated: May 19, 2026

Bronchial Thermoplasty: A Novel Therapeutic Approach to Severe Asthma
Published on: November 4, 2010
梅波利祖马布用于严重的酸性喘 (DREAM):多中心,双盲,安慰剂对照试验
Ian D Pavord1, Stephanie Korn, Peter Howarth
1Institute for Lung Health, University Hospitals of Leicester NHS Trust, Glenfield Hospital, Leicester, UK. ian.pavord@uhl-tr.nhs.uk
梅波利祖马布显著减少了患有严重酸性喘的患者的喘恶化. 这种单克隆抗体治疗有效且耐受性良好,为治疗严重呼吸系统疾病提供了新的选择.
科学领域:
- 肺部病理学 肺部病理学
- 免疫学 免疫学 免疫学
- 临床试验 临床试验
背景情况:
- 严重的喘通常与埃索诺菲尔呼吸道炎症和反复恶化有关.
- 针对互白素-5的单克隆抗体梅波利祖马布 (Mepolizumab) 已经显示出降低这些恶化的潜力.
研究的目的:
- 评估梅波利祖马布在患有严重酸性喘的患者中的疗效和安全性.
- 为了确定与治疗反应相关的患者特征.
主要方法:
- 一个多中心,双盲,安慰剂对照试验,涉及621名患有严重喘和eosinophilic炎症的患者.
- 患者每4周接受静脉注射梅波利祖马布 (75毫克,250毫克或750毫克) 或安慰剂,进行13次输液.
- 主要结局是临床显著喘恶化率.
主要成果:
- 与安慰剂相比,梅波利祖马布在所有测试剂量中显著降低了喘恶化率.
- 降低范围在39%至52%之间 (p<0.0001对于75毫克和750毫克剂量).
- 发生了三起死亡,被认为与研究治疗无关.
结论:
- 梅波利祖马布是一种有效且耐受性良好的治疗方法,用于减少严重酸性喘的恶化.
- 这项研究支持mepolizumab作为这种患者群体的有价值的治疗选择.
更多相关视频
04:53Acupoint Application Combined with Ear Plaster Therapy for Treating Sleep Disorders with Acute Exacerbation of Chronic Obstructive Pulmonary Disease
Published on: October 18, 2024
07:28Dry Powder and Nebulized Aerosol Inhalation of Pharmaceuticals Delivered to Mice Using a Nose-only Exposure System
Published on: April 6, 2017
相关概念视频
Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Antiasthma Drugs: Leukotriene Modifiers
Leukotriene modifiers work through two distinct mechanisms:
Asthma III: Clinical Manifestations
Asthma I: Introduction
Asthma-IV: Diagnostic and Management
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
Antiasthma Drugs: Methylxanthines
Theophylline is thought to inhibit phosphodiesterase enzymes, increasing intracellular levels of cyclic adenosine monophosphate (cAMP) and cyclic guanosine monophosphate (cGMP). This rise in cAMP and cGMP concentrations stimulates cardiac function,...